Filter Specialty
Filterspecialty
Submit To The Journals
Previous
Article
Next
Article

Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome

Heart International. 2017;12(1):e18-e23 https://doi.org/10.5301/heartint.5000237

Abstract

Introduction. Administering optimal cardiovascular medication (OCM) to patients with hypertension (HBP) and ischemic heart disease (IHD) lowers cardiovascular morbidity and mortality. The main objective of this study was to compare in-hospital cardiac mortality among patients with HBP and/or IHD, treated or untreated with OCM, who developed a first episode of acute coronary syndrome (ACS). Methods. The study was carried out retrospectively and included patients admitted with a first episode of ACS between 2013 and 2016. The patients were divided into three groups: those with HBP, IHD, and a history of HBP + IHD. Patients were then divided into two subgroups: subgroup A consisted of patients undergoing optimal anti- ischemic and/or antihypertensive therapy, while subgroup B consisted of patients without OCM. Results. This analysis comprised 1096 patients. Mean age was 64.3 ± 18 years. There were 581 patients in subgroup A – 53%, and 515 patients in subgroup B – 47%. Total cardiac mortality was 9.98%, different depending on the groups and subgroups studied: HBP group total – 7%, subgroup A – 5.1%, significantly lower compared to subgroup B – 9.4% (p = 0.05); IHD group total – 12.2%, subgroup A – 9.07%, significantly lower compared to subgroup B – 15.8% (p = 0.05); HBP + IHD group total – 14.35%, subgroup A – 9.9%, significantly lower compared to subgroup B – 18.8% (p = 0.05). Conclusions. The lack of OCM in patients with HBP and/or IHD is correlated to a significant increase in in-hospital cardiac mortality among patients who develop a first-episode ACS.

Keywords

Acute coronary syndrome, Cardiac mortality, Hypertension, Ischemic heart disease, Optimal cardio - vascular medication

Disclosure

Financial support: No grants or funding have been received for this study.

Accepted

2017-09-18T00:00:00

Published Online

October 14, 2017

Correspondence

Călin Pop George Cosbuc Street nr 31 Baia Mare, Romania medicbm@yahoo.com

  • Touch Medical Media Limited, trading as Touch Medical Media, is a private limited company registered in England and Wales at The White House, Mill Road, Goring, Reading, England, RG8 9DD with registered number 08197142. © 2019 All rights reserved.

    touchcardio is for informational purposes and intended for healthcare professionals only. Its content should not be considered medical advice, diagnosis or treatment recommendations.